BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2948131)

  • 1. Serum profiles of the regulatory complement proteins during the progression of renal damage in human glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Germinario C; Balletta M; Andreucci VE
    Nephron; 1986; 44(4):272-6. PubMed ID: 2948131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercomplementemia in adult patients with IgA nephropathy.
    Onda K; Ohi H; Tamano M; Ohsawa I; Wakabayashi M; Horikoshi S; Fujita T; Tomino Y
    J Clin Lab Anal; 2007; 21(2):77-84. PubMed ID: 17385664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of complement activation in membranous and membranoproliferative glomerulonephritis.
    Moseley HL; Whaley K
    Kidney Int; 1980 Apr; 17(4):535-44. PubMed ID: 6446614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement factors in fetal and maternal blood and amniotic fluid during the second trimester of normal pregnancy.
    Stabile I; Nicolaides KH; Bach A; Teisner B; Rodeck C; Westergaard JG; Grudzinskas JG
    Br J Obstet Gynaecol; 1988 Mar; 95(3):281-5. PubMed ID: 2967090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for glomerular modulation of complement activation.
    Moseley HL; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):9-13. PubMed ID: 95813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of serum C3 levels by beta 1H and C3b inactivator.
    Wyatt RJ; Forristal J; Davis CA; Coleman TH; West CD
    J Lab Clin Med; 1980 Jun; 95(6):905-17. PubMed ID: 6445926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of factors of the alternative pathway].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():630-3. PubMed ID: 2141369
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
    Langlois PF; Gawryl MS
    Atherosclerosis; 1988 Mar; 70(1-2):95-105. PubMed ID: 3258520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic and prognostic value of complement in nephrotic syndromes].
    Schena FP; Pertosa G; Vox E; Mastrolitti G
    Minerva Nefrol; 1981; 28(3):387-92. PubMed ID: 7036019
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intraocular lenses on complement levels in human serum.
    Mondino BJ; Rao H
    Acta Ophthalmol (Copenh); 1983 Feb; 61(1):76-84. PubMed ID: 6407275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy.
    Endo M; Ohi H; Satomura A; Hidaka M; Ohsawa I; Fujita T; Kanmatsuse K; Matsushita M; Fujita T
    Clin Nephrol; 2001 Mar; 55(3):185-91. PubMed ID: 11316237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
    Potter BJ; Brown DJ; Watson A; Jewell DP
    Gut; 1980 Dec; 21(12):1030-4. PubMed ID: 6450718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum complement composition of myasthenia gravis].
    Hao ZS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):141-3, 190. PubMed ID: 2591267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections.
    Otesile EB; Lee M; Tabel H
    J Parasitol; 1991 Dec; 77(6):958-64. PubMed ID: 1838113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and function of the classical and alternative pathways of complement.
    Ogle JD; Ogle CK
    Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
    Kapp A; Wokalek H; Schöpf E
    Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interferon-gamma on complement gene expression in different cell types.
    Lappin DF; Guc D; Hill A; McShane T; Whaley K
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of laboratory findings in patients with glomerulonephritis classified according to histopathologic diagnosis.
    Kirac Y; Bilen S; Duranay M
    Minerva Med; 2014 Apr; 105(2):149-56. PubMed ID: 24727879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.